Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience

por Lo Re, Giovanni, Santeufemia, Davide A., Foltran, Luisa, Bidoli, Ettore, Basso, Stefano M.M., Lumachi, Franco
Publicado 2015